Medications ›physostigmine salicylate

physostigmine salicylate

RxCUI 33656 precise ingredient

Contraindicated with · 33

Diagnoses11

Gangrene Ureteral Obstruction Intestinal Obstruction Diabetes Mellitus Necrosis Asthma Lung Diseases, Obstructive Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Drug Hypersensitivity

Condition families22

Ureteral Diseases Glucose Metabolism Disorders Bronchial Diseases Endocrine System Diseases Intestinal Diseases Gastrointestinal Diseases Metabolic Diseases Lung Diseases Urologic Diseases Nutritional and Metabolic Diseases Male Urogenital Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Respiratory Tract Diseases Digestive System Diseases Cardiovascular Diseases Urogenital Diseases Pathologic Processes Immune System Diseases Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 8

Diagnoses3

Abnormalities, Drug-Induced Glaucoma Ocular Hypertension

Condition families5

Congenital Abnormalities Eye Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.